Stock listing
KRX:003000 Bukwang Pharmaceutical Co., Ltd. (부광약품) 주가
Follow Bukwang Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:003000
₩3,800.00 KRW -65.00 (-1.7%)
Close on Nov 20, 2026
- Day range
- ₩3,760.00 – ₩3,865.00 KRWNov 20, 2026
- Volume
- 242,575 sharesNov 20, 2026
- Market cap
- ₩374.9B KRWAt the close on Nov 20, 2026 · price × 98.66M shares outstanding
- 52-week range
- ₩3,580.00 – ₩9,890.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩1.64B KRWMedian day 221,381 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:003000 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩3,800.00 | -65.00 | -1.7% | ₩3,820.00 | ₩3,865.00 | ₩3,760.00 | 242,575 | |
| ₩3,865.00 | -5.00 | -0.1% | ₩3,865.00 | ₩3,990.00 | ₩3,755.00 | 217,124 | |
| ₩3,870.00 | -20.00 | -0.5% | ₩3,860.00 | ₩3,950.00 | ₩3,830.00 | 172,763 | |
| ₩3,890.00 | -95.00 | -2.4% | ₩4,020.00 | ₩4,020.00 | ₩3,865.00 | 121,798 | |
| ₩3,985.00 | +35.00 | +0.9% | ₩3,960.00 | ₩4,065.00 | ₩3,940.00 | 159,315 | |
| ₩3,950.00 | -125.00 | -3.1% | ₩4,075.00 | ₩4,110.00 | ₩3,925.00 | 175,789 | |
| ₩4,075.00 | +70.00 | +1.7% | ₩3,995.00 | ₩4,135.00 | ₩3,985.00 | 396,821 | |
| ₩4,005.00 | +180.00 | +4.7% | ₩3,825.00 | ₩4,010.00 | ₩3,825.00 | 257,906 | |
| ₩3,825.00 | +25.00 | +0.7% | ₩3,820.00 | ₩3,940.00 | ₩3,795.00 | 401,155 | |
| ₩3,800.00 | -55.00 | -1.4% | ₩3,810.00 | ₩3,880.00 | ₩3,705.00 | 422,806 | |
| ₩3,855.00 | +15.00 | +0.4% | ₩3,830.00 | ₩3,940.00 | ₩3,815.00 | 379,860 | |
| ₩3,840.00 | +155.00 | +4.2% | ₩3,790.00 | ₩3,840.00 | ₩3,675.00 | 300,317 | |
| ₩3,685.00 | -10.00 | -0.3% | ₩3,710.00 | ₩3,730.00 | ₩3,630.00 | 210,591 | |
| ₩3,695.00 | +25.00 | +0.7% | ₩3,630.00 | ₩3,730.00 | ₩3,630.00 | 134,799 | |
| ₩3,670.00 | -30.00 | -0.8% | ₩3,665.00 | ₩3,750.00 | ₩3,625.00 | 255,548 | |
| ₩3,700.00 | -50.00 | -1.3% | ₩3,750.00 | ₩3,765.00 | ₩3,640.00 | 225,637 | |
| ₩3,750.00 | -5.00 | -0.1% | ₩3,780.00 | ₩3,795.00 | ₩3,730.00 | 214,340 | |
| ₩3,755.00 | +95.00 | +2.6% | ₩3,690.00 | ₩3,755.00 | ₩3,655.00 | 413,197 | |
| ₩3,660.00 | -140.00 | -3.7% | ₩3,700.00 | ₩3,795.00 | ₩3,660.00 | 191,636 | |
| ₩3,800.00 | -65.00 | -1.7% | ₩3,835.00 | ₩3,915.00 | ₩3,740.00 | 255,240 | |
| ₩3,865.00 | -25.00 | -0.6% | ₩3,890.00 | ₩3,930.00 | ₩3,815.00 | 135,073 | |
| ₩3,890.00 | -25.00 | -0.6% | ₩3,940.00 | ₩4,020.00 | ₩3,880.00 | 166,934 | |
| ₩3,915.00 | -30.00 | -0.8% | ₩3,905.00 | ₩3,995.00 | ₩3,875.00 | 147,574 | |
| ₩3,945.00 | +45.00 | +1.2% | ₩3,890.00 | ₩3,950.00 | ₩3,835.00 | 181,716 | |
| ₩3,900.00 | +220.00 | +6.0% | ₩3,685.00 | ₩3,970.00 | ₩3,685.00 | 337,495 | |
| ₩3,680.00 | -155.00 | -4.0% | ₩3,795.00 | ₩3,795.00 | ₩3,635.00 | 470,646 | |
| ₩3,835.00 | -75.00 | -1.9% | ₩3,910.00 | ₩3,970.00 | ₩3,815.00 | 199,359 | |
| ₩3,910.00 | -10.00 | -0.3% | ₩3,860.00 | ₩4,025.00 | ₩3,775.00 | 673,866 | |
| ₩3,920.00 | -135.00 | -3.3% | ₩4,055.00 | ₩4,095.00 | ₩3,915.00 | 393,517 | |
| ₩4,055.00 | -215.00 | -5.0% | ₩4,205.00 | ₩4,225.00 | ₩3,900.00 | 448,548 | |
| ₩4,270.00 | +120.00 | +2.9% | ₩4,215.00 | ₩4,785.00 | ₩4,155.00 | 2,523,490 | |
| ₩4,150.00 | +50.00 | +1.2% | ₩4,150.00 | ₩4,200.00 | ₩4,085.00 | 275,741 | |
| ₩4,100.00 | -55.00 | -1.3% | ₩4,165.00 | ₩4,230.00 | ₩4,080.00 | 207,832 | |
| ₩4,155.00 | +135.00 | +3.4% | ₩4,050.00 | ₩4,155.00 | ₩4,020.00 | 333,678 | |
| ₩4,020.00 | +50.00 | +1.3% | ₩4,025.00 | ₩4,070.00 | ₩3,975.00 | 146,673 | |
| ₩3,970.00 | -40.00 | -1.0% | ₩3,965.00 | ₩4,010.00 | ₩3,950.00 | 103,251 | |
| ₩4,010.00 | +80.00 | +2.0% | ₩3,970.00 | ₩4,065.00 | ₩3,925.00 | 204,083 | |
| ₩3,930.00 | -5.00 | -0.1% | ₩3,990.00 | ₩4,000.00 | ₩3,930.00 | 91,081 | |
| ₩3,935.00 | -85.00 | -2.1% | ₩4,020.00 | ₩4,045.00 | ₩3,935.00 | 178,294 | |
| ₩4,020.00 | +15.00 | +0.4% | ₩4,020.00 | ₩4,020.00 | ₩3,945.00 | 149,283 | |
| ₩4,005.00 | +70.00 | +1.8% | ₩3,975.00 | ₩4,040.00 | ₩3,960.00 | 249,305 | |
| ₩3,935.00 | +5.00 | +0.1% | ₩3,885.00 | ₩3,980.00 | ₩3,885.00 | 162,591 | |
| ₩3,930.00 | +85.00 | +2.2% | ₩3,860.00 | ₩3,940.00 | ₩3,820.00 | 188,457 | |
| ₩3,845.00 | -45.00 | -1.2% | ₩3,895.00 | ₩3,975.00 | ₩3,825.00 | 653,745 | |
| ₩3,890.00 | -80.00 | -2.0% | ₩3,970.00 | ₩3,975.00 | ₩3,845.00 | 724,090 | |
| ₩3,970.00 | -120.00 | -2.9% | ₩4,050.00 | ₩4,095.00 | ₩3,930.00 | 873,298 | |
| ₩4,090.00 | -35.00 | -0.8% | ₩4,110.00 | ₩4,125.00 | ₩4,025.00 | 193,799 | |
| ₩4,125.00 | +50.00 | +1.2% | ₩4,080.00 | ₩4,125.00 | ₩4,075.00 | 207,136 | |
| ₩4,075.00 | -30.00 | -0.7% | ₩4,130.00 | ₩4,195.00 | ₩4,070.00 | 268,075 | |
| ₩4,105.00 | +25.00 | +0.6% | ₩4,130.00 | ₩4,195.00 | ₩4,080.00 | 317,390 | |
| ₩4,080.00 | +40.00 | +1.0% | ₩4,050.00 | ₩4,155.00 | ₩4,020.00 | 348,392 | |
| ₩4,040.00 | -25.00 | -0.6% | ₩4,075.00 | ₩4,165.00 | ₩4,030.00 | 459,074 | |
| ₩4,065.00 | -315.00 | -7.2% | ₩4,380.00 | ₩4,545.00 | ₩4,065.00 | 1,166,636 | |
| ₩4,380.00 | +195.00 | +4.7% | ₩4,190.00 | ₩4,875.00 | ₩4,140.00 | 4,811,517 | |
| ₩4,185.00 | -15.00 | -0.4% | ₩4,235.00 | ₩4,235.00 | ₩4,085.00 | 132,573 | |
| ₩4,200.00 | +30.00 | +0.7% | ₩4,150.00 | ₩4,220.00 | ₩4,105.00 | 134,897 | |
| ₩4,170.00 | -40.00 | -1.0% | ₩4,210.00 | ₩4,215.00 | ₩4,100.00 | 167,055 | |
| ₩4,210.00 | +60.00 | +1.4% | ₩4,200.00 | ₩4,215.00 | ₩4,120.00 | 162,469 | |
| ₩4,150.00 | -5.00 | -0.1% | ₩4,155.00 | ₩4,155.00 | ₩3,970.00 | 169,067 | |
| ₩4,155.00 | +25.00 | +0.6% | ₩4,135.00 | ₩4,225.00 | ₩4,090.00 | 153,432 | |
| ₩4,130.00 | -160.00 | -3.7% | ₩4,250.00 | ₩4,255.00 | ₩4,070.00 | 296,730 | |
| ₩4,290.00 | +90.00 | +2.1% | ₩4,395.00 | ₩4,820.00 | ₩4,285.00 | 562,046 |
Splits
12 splits since 2007 · KRX:003000 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 11-for-10 | Split | |
| 21-for-20 | Split | |
| 13-for-10 | Split | |
| 11-for-10 | Split | |
| 6-for-5 | Split | |
| 11-for-10 | Split | |
| 11-for-10 | Split | |
| 21-for-20 | Split | |
| 21-for-20 | Split | |
| 21-for-20 | Split | |
| 21-for-20 | Split | |
| 21-for-20 | Split |
- Ticker
- KRX:003000
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · Apr 21, 2026
Bukwang Pharm Q1 Operating Profit 1 Billion Won, Down 62.6% From Year Earlier
Latest news
Bukwang Pharm Q1 Operating Profit 1 Billion Won, Down 62.6% From Year Earlier
Apr 21, 2026
Closed ₩7,290.00 (-6.9%) on Apr 21, 2026
Bukwang Pharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 1 in the last 12 months · 2 in all · newest Apr 21, 2026 · oldest 2025
Valuation
P/E 42.7× against a median of 41.2×: 3rd lowest of 4 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩205.8B KRW
- P/E
- 42.7×
- EV/sales
- 1.0×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 1.1×
- Gross margin
- 44.5%
- Operating margin
- 5.4%
- Net margin
- 4.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bukwang Pharmaceutical Co., Ltd. · KRX:003000 | US$278.7M | US$153.0M | 42.7× | 1.0× | n/a | 1.1× | 4.1% | 0.0× | n/a |
| ARS Pharmaceuticals, Inc. · NASDAQ:SPRY | US$297.6M | US$281.0M | n/a | 2.3× | n/a | n/a | −163.6% | n/a | 2.09 |
| Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A · SSE:605199 | US$287.7M | US$344.3M | n/a | 3.8× | n/a | 7.2× | −68.9% | 1.5× | n/a |
| Chengdu Huasun Technology Group Inc., Ltd. Class A · SZSE:000790 | US$285.5M | US$277.5M | n/a | 4.4× | n/a | 2.7× | −57.2% | 0.1× | n/a |
| Tiansheng Pharmaceutical Group Co. Ltd. Class A · SZSE:002872 | US$279.7M | US$239.5M | n/a | 3.1× | n/a | 1.0× | −10.6% | 0.0× | n/a |
| Ildong Pharmaceutical Co., Ltd. · KRX:249420 | US$278.0M | US$233.1M | 8.6× | 0.5× | 6.3× | 1.4× | 7.5% | 0.0× | n/a |
| Deva Holding A.S. · BIST:DEVA | US$276.9M | US$245.0M | n/a | 0.6× | 4.4× | 0.4× | −3.9% | 0.1× | n/a |
| Honz Pharmaceutical Co., Ltd. Class A · SZSE:300086 | US$276.0M | US$298.2M | n/a | 5.9× | n/a | 2.2× | −62.4% | 0.2× | n/a |
| Shandong Sito Bio-technology Co., Ltd. Class A · SZSE:300583 | US$272.2M | US$254.6M | 62.3× | 1.5× | n/a | 1.0× | 2.6% | 0.1× | n/a |
| Lavipharm SA · ATHEX:LAVI | US$271.0M | US$309.0M | 41.2× | 4.5× | 22.8× | 4.4× | 9.6% | 0.7× | n/a |
| Zhejiang East Asia Pharmaceutical Co., Ltd. Class A · SSE:605177 | US$264.1M | US$340.3M | n/a | 2.4× | n/a | 1.1× | −21.8% | 0.5× | n/a |
| Median of the others | US$277.5M | US$279.2M | 41.2× | 2.8× | 6.3× | 1.4× | −16.2% | 0.1× | 2.09 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | Apr 20, 2026 · Before open | −3.0% |
| Q3 2025 | Oct 20, 2025 · Before open | +1.0% |
| Q1 2025 | Apr 21, 2025 · After close | +0.3% |
| Q4 2024 | Feb 6, 2025 · Before open | +0.5% |
| Q3 2024 | Oct 22, 2024 · After close | +1.2% |
| Q2 2024 | Aug 13, 2024 · Before open | −2.5% |
| Q1 2024 | Apr 23, 2024 · After close | +1.0% |
| Q4 2023 | Feb 29, 2024 · Before open | 0.0% |
| Q3 2023 | Nov 13, 2023 · After close | −0.7% |
| Q2 2023 | Aug 10, 2023 | +0.7% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | May 15, 2023 · Before open | −0.5% |
| Q4 2022 | Jan 31, 2023 · Before open | +2.2% |
| Q3 2022 | Nov 11, 2022 · Before open | +2.2% |
| Q2 2022 | Aug 15, 2022 · After close | −0.5% |
| Q1 2022 | May 13, 2022 · Before open | +3.9% |
| Q3 2021 | Nov 12, 2021 · Before open | +3.2% |
| Quarter to Jun 30, 2021 | Aug 13, 2021 · Before open | −2.9% |
| Quarter to Mar 31, 2021 | May 14, 2021 · Before open | −0.5% |
| Quarter to Dec 31, 2020 | Mar 11, 2021 · After close | +0.4% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 200.7B | 160.1B | 125.9B | 190.9B | 182.5B | 169.7B | 168.2B | 194.2B | 150.7B | 138.6B |
| Cost of revenue | 108.8B | 85.7B | 78.9B | 111.5B | 106.7B | 98.0B | 83.9B | 79.2B | 70.1B | 62.3B |
| Gross profit | 91.9B | 74.3B | 47.1B | 79.4B | 75.8B | 71.6B | 84.2B | 115.0B | 80.6B | 76.3B |
| Research and development | 19.4B | 23.4B | 34.6B | 24.3B | 22.5B | 18.0B | 17.3B | 24.6B | 25.1B | 18.7B |
| Selling, general and administrative | 24.8B | 16.8B | 22.1B | 19.8B | 13.5B | 15.3B | 22.2B | 20.1B | 16.5B | 18.7B |
| Operating income | 14.2B | 1.62B | -37.5B | -230.6M | 5.62B | 4.03B | 9.54B | 35.1B | 7.68B | 8.54B |
| Depreciation and amortization | 5.49B | 4.11B | 4.29B | 5.12B | 4.84B | 6.16B | 5.84B | 6.88B | 6.10B | 5.70B |
| EBITDA | 19.7B | 5.72B | -33.2B | 4.89B | 10.5B | 10.2B | 15.4B | 42.0B | 13.8B | 14.2B |
| Interest expense | 3.90B | 6.49B | 3.81B | 1.76B | 1.41B | 1.51B | 90.9M | 0 | 0 | 0 |
| Income before tax | 6.39B | -2.97B | -39.6B | -1.03B | 3.79B | -8.30B | -1.36B | 191.1B | 14.9B | 21.0B |
| Income tax | 6.58B | 1.81B | 6.07B | 45.4B | 3.79B | 5.22B | ||||
| Net income | 12.6B | -2.64B | -31.3B | -2.47B | -916.6M | -7.20B | -7.41B | 145.7B | 11.1B | 15.8B |
| Earnings per share, basic | 127.28 | -35.43 | -457.67 | -33.19 | -13.39 | -115.71 | -110.56 | 2,580.74 | 171.54 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 96.2B | 90.1B | 151.2B | 85.5B | 82.8B | 79.3B | 37.6B | 100.4B | 24.2B | 41.1B |
| Short-term investments | 120.0B | 40.0B | 1.50B | 10.3B | ||||||
| Receivables | 27.8B | 23.6B | 35.7B | 88.0B | 90.4B | 103.7B | 103.0B | 86.6B | 60.2B | 50.3B |
| Inventory | 52.2B | 41.7B | 56.8B | 38.6B | 39.3B | 51.4B | 44.1B | 34.2B | 39.6B | 39.4B |
| Current assets | 303.2B | 203.7B | 254.2B | 218.7B | 220.1B | 248.2B | 186.4B | 221.6B | 124.3B | 134.0B |
| Property, plant and equipment | 124.5B | 106.3B | 128.8B | 128.5B | 60.2B | 60.9B | ||||
| Goodwill | 0 | 406.6M | 878.7M | 834.5M | 828.7M | 827.0M | 796.8M | 786.5M | 788.9M | 782.7M |
| Total assets | 476.3B | 373.2B | 429.0B | 400.9B | 397.4B | 401.0B | 388.5B | 493.6B | 236.2B | 237.6B |
| Accounts payable | 7.30B | 5.06B | 2.37B | 16.5B | 7.42B | 10.2B | 9.89B | 4.34B | 4.68B | 3.28B |
| Current liabilities | 117.8B | 35.4B | 97.5B | 44.6B | 37.0B | 61.2B | 35.9B | 38.2B | 19.2B | 16.8B |
| Long-term debt | 79.0B | 78.5B | ||||||||
| Total liabilities | 135.4B | 129.0B | 194.8B | 129.1B | 117.4B | 129.8B | 62.0B | 80.2B | 24.9B | 23.0B |
| Shareholders' equity | 340.6B | 243.7B | 226.3B | 263.2B | 269.6B | 258.5B | 326.2B | 413.4B | 211.3B | 214.6B |
| Shares outstanding | 98.7M | 74.6M | 68.5M | 74.6M | 68.5M | 62.3M | 67.0M | 56.4M | 64.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 21.5B | 34.4B | -9.36B | 16.5B | 26.5B | 723.2M | -23.4B | 6.82B | 8.56B | -7.76B |
| Capital spending | -11.2B | -2.61B | -2.83B | -4.99B | -785.1M | -1.92B | -3.54B | -3.71B | -4.49B | -5.93B |
| Free cash flow | 10.3B | 31.7B | -12.2B | 11.5B | 25.7B | -1.23B | -28.3B | 3.09B | 2.03B | -13.7B |
| Cash from investing | 4.75B | 13.0B | 18.1B | 35.0B | -7.45B | 3.59B | ||||
| Cash from financing | -27.5B | 28.2B | -57.5B | 34.5B | -18.0B | -22.3B | ||||
| Dividends paid | -4.93B | -6.85B | -6.23B | -12.2B | -9.77B | -8.61B | -17.9B | -22.8B | ||
| Share buybacks | -2.75B | -516.2M | -25.1B | -50.2B | -110.0M | -80.3M | -87.1M | |||
| Change in cash | 6.12B | -61.1B | 65.7B | 2.74B | 3.49B | 41.7B | -62.8B | 76.2B | -16.9B | -26.4B |
Cap table
Built by 6ix from Bukwang Pharmaceutical Co., Ltd.’s releases
- Common shares
- 98,664,671
- Fully diluted
- 98,664,671
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 98,664,671 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 98,664,671 |
Log in to ask 6ix AI your own questions about Bukwang Pharmaceutical Co., Ltd.